Get analyst updates on this IPO
Analyst updates come by email.Too many attempts. Please wait a few minutes and try again.
What changed since listing, from SEBI-registered research analysts.
By continuing you agree to the Terms and Privacy policy
Key facts
- Lot amount at the upper band
- ₹1,35,000
- Computed from the issue price (Prospectus dated Tue 27 Jan 2026, page 2)
- Issue size at the upper band
- ₹77.49 crore
Timeline (IST)
- OpensWed 21 Jan 2026, 10:00 am IST confirmedProspectus dated Tue 27 Jan 2026, page 82
- ClosesFri 23 Jan 2026, 3:00 pm IST confirmedProspectus dated Tue 27 Jan 2026, page 82
- UPI mandate cut-offFri 23 Jan 2026, 5:00 pm IST confirmedProspectus dated Tue 27 Jan 2026, page 1
- AllotmentTue 27 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400
- Refund and unblockTue 27 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400
- Shares to dematWed 28 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400
- ListingThu 29 Jan 2026 confirmedProspectus dated Tue 27 Jan 2026, page 400
Objects of the issue
| Object | Amount |
|---|---|
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | ₹13.67 crore |
| Purchase of CRM Software and Hardware Infrastructure | ₹1.42 crore |
| Human Resources | ₹5.44 crore |
| Repayment/Prepayment of loan | ₹12.50 crore |
| Working Capital Requirement | ₹22.90 crore |
| General Corporate Purposes | ₹10.00 crore |
| Total | ₹65.92 crore |
Figures may not add up due to rounding.
Prospectus dated Tue 27 Jan 2026, page 116
Company and promoters
As described in the prospectus
Our Company, established in 2019, is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.
Prospectus dated Tue 27 Jan 2026, page 196
Promoters
- 2 individual promoters
Prospectus dated Tue 27 Jan 2026, page 305
Shareholding
| Holding | Before the issue | After the issue |
|---|---|---|
| Promoters and promoter group | 92.16% | Not stated in the prospectus |
| Public | 7.84% | Not stated in the prospectus |
Prospectus dated Tue 27 Jan 2026, page 99
Financials (restated)
| Item | September 30, 2025 | March 31, 2025 | March 31, 2024 | March 31, 2023 |
|---|---|---|---|---|
| Revenue from operations | ₹48.36 crore | ₹76.55 crore | ₹67.16 crore | ₹89.29 crore |
| Profit after tax | ₹8.14 crore | ₹12.10 crore | ₹3.41 crore | ₹7.60 crore |
| Net worth | ₹36.13 crore | ₹23.88 crore | ₹11.78 crore | ₹8.37 crore |
| Total borrowings | ₹25.07 crore | ₹31.20 crore | ₹23.18 crore | ₹19.87 crore |
Prospectus dated Tue 27 Jan 2026, page 28
SME issue facts
- The Offer consists of a Fresh Issue by our Company. (Prospectus dated Tue 27 Jan 2026, page 395)
- Allocation and allotment of Equity Shares through this Issue will be done in multiples of 1000 Equity Shares subject to a minimum allotment of 1000 Equity Shares to the successful Applicants (Prospectus dated Tue 27 Jan 2026, page 397)
- our Company shall ensure that the minimum application size shall not be less than two lots. Provided that the minimum application size shall be above Rs.2 lakhs. (Prospectus dated Tue 27 Jan 2026, page 397)
- The trading of the Equity Shares will happen in the minimum contract size of 1,000 Equity Shares (Prospectus dated Tue 27 Jan 2026, page 397)
- the minimum number of allottees in this Issue shall be 200 shareholders. (Prospectus dated Tue 27 Jan 2026, page 398)
Peer comparison (as in the Prospectus)
| S.no | Name of the company | Face Value (Rs. Per share) | CMP(Rs.) | EPS (Rs) | P/E Ratio | RONW (%) | NAV (Rs. Per share) | PAT (Amt. In Lakhs) |
|---|---|---|---|---|---|---|---|---|
| 1 | KRM Ayurveda Limited | 10 | - | 5.24 | - | 27.13% | 25.64 | 813.92 |
| 2 | Jeena Sikho Lifecare Ltd. | 2 | 684.20 | 8.86 | 77.22 | 31.28% | 142.24 | 11,009.72 |
| 3 | Vaidya Sane Ayurved Laboratories Ltd | 10 | 234.00 | 3.07 | 76.22 | 5.12% | 59.85 | 322.39 |
Reproduced from the Prospectus dated Tue 27 Jan 2026, page 139; InsightPier adds no figures
Risk factors
74 total- The registered office and hospital premises are rented, not owned, and losing them could disrupt operations (offer document page 35)
- The company has a high rate of employee attrition, including frontline and technical staff (offer document page 37)
- Most state-wise revenue comes from two states (Delhi and Haryana), so local setbacks could hurt results (offer document page 37)
- The business needs a lot of working capital, and shortfalls in financing it could hurt results (offer document page 38)
- Being a listed company adds compliance and reporting costs that may strain resources (offer document page 74)
All 74 risk factors, pages 34 to 74
Offer document
Allotment and bids
Registrar to the issue: Skyline Financial Services Private Limited.
Allotment status is on the registrar's site, from Tue 27 Jan 2026. Pick "KRM Ayurveda Ltd." from the issue list there.